METHOD FOR INTEGRATED TREATMENT OF MALE NORMOGONADOTROPIC INFERTILITY Russian patent published in 2013 - IPC A61N5/00 A61K31/138 A61K33/18 A61K38/24 A61P15/08 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to urology and endocrinology, and may be used in the integrated treatment of male normogonadotropic infertility. For this purpose, the conventional therapeutic regimens are added with administration of follitropin alpha (gopal-f) subcutaneously three times a week, 150 IU for 6 weeks. In addition, blood is exposed to UV irradiation for 20 minutes, 2 times a week; the therapeutic course is 12 procedures.

EFFECT: method provides anti-inflammatory and immune stimulating action, as well as ensures the effective treatment ensured by the high stimulating capacity of spermatogenesis, improves endocrine organs promoting their recovery by improving microcirculation that causes the therapeutic effect and extends the range of therapeutic activities with reduced the length of treatment and requires no staying in hospital.

2 ex, 2 tbl